MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers.
about
mRNAs and miRNAs in whole blood associated with lung hyperplasia, fibrosis, and bronchiolo-alveolar adenoma and adenocarcinoma after multi-walled carbon nanotube inhalation exposure in miceIncreased miR-708 expression in NSCLC and its association with poor survival in lung adenocarcinoma from never smokersOverlapping functions of microRNAs in control of apoptosis during Drosophila embryogenesisMolecular biology of lung cancer: clinical implicationsRho-associated kinases in tumorigenesis: re-considering ROCK inhibition for cancer therapyMicroRNA In Lung Cancer: Novel Biomarkers and Potential Tools for TreatmentRole of microRNAs in chemoresistanceMicroRNAs and Growth Factors: An Alliance Propelling Tumor ProgressionEmerging Roles of MicroRNAs in EGFR-Targeted Therapies for Lung CancerMicroRNAs in respiratory disease. A clinician's overviewSNPing cancer in the bud: microRNA and microRNA-target site polymorphisms as diagnostic and prognostic biomarkers in cancerNon-coding RNAs in lung cancerAlterations of microRNAs contribute to colon carcinogenesisCan microRNAs improve the management of lung cancer patients? A clinician's perspectiveRole of Exosomal Noncoding RNAs in Lung CarcinogenesisMicroRNAs in flow-dependent vascular remodellingRegulating miRNA by natural agents as a new strategy for cancer treatmentEnzastaurin has anti-tumour effects in lung cancers with overexpressed JAK pathway molecules.MicroRNA-21 modulates the levels of reactive oxygen species by targeting SOD3 and TNFαSuppression of miR-204 enables oral squamous cell carcinomas to promote cancer stemness, EMT traits, and lymph node metastasisThe role of epigenetics in resistance to Cisplatin chemotherapy in lung cancerOverexpression of deubiquitinating enzyme USP28 promoted non-small cell lung cancer growthBioinformatics of Cancer ncRNA in High Throughput Sequencing: Present State and ChallengesInflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways.Non-small cell lung cancer associated microRNA expression signature: integrated bioinformatics analysis, validation and clinical significance.Cigarette smoke induces C/EBP-β-mediated activation of miR-31 in normal human respiratory epithelia and lung cancer cells.ABCG1 as a potential oncogene in lung cancerThe new concepts on overcoming drug resistance in lung cancer.MicroRNA Signature of Lung Adenocarcinoma with EGFR Exon 19 DeletionDehydroepiandrosterone-induces miR-21 transcription in HepG2 cells through estrogen receptor β and androgen receptorMolecular mechanisms of acquired resistance to tyrosine kinase targeted therapyThe low expression of miR-451 predicts a worse prognosis in non-small cell lung cancer cases.Implication of microRNAs in drug resistance for designing novel cancer therapymicroRNAs and lung cancer: tumors and 22-mers.MicroRNA expression distinguishes SCLC from NSCLC lung tumor cells and suggests a possible pathological relationship between SCLCs and NSCLCsmiR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosisIdentification of a microRNA signature of renal ischemia reperfusion injury.MicroRNAs and lung cancer: Biology and applications in diagnosis and prognosis.MicroRNA-21 is involved in ionizing radiation-promoted liver carcinogenesis.Downregulation of the Rho GTPase signaling pathway is involved in the microRNA-138-mediated inhibition of cell migration and invasion in tongue squamous cell carcinoma.
P2860
Q23910476-99A9F004-83BD-4480-BFF5-1B1BEDA608A0Q24595630-834991A1-8305-4590-BC9E-0BD52EDB043FQ24602019-65F31883-6A00-4BC8-9365-48889154A598Q24610335-AB62899B-A78D-4211-8E58-75F214734C5EQ24631326-96B0B56A-7E93-4690-9F48-C680775F7533Q26752548-4C0B47AB-534E-4737-BFFF-FDC248397DDFQ26770485-A9D41AEA-2654-4299-BDE9-8D093234BDC6Q26796592-1705C019-46F1-4DB1-B478-B7CB3BBB439DQ26798147-5AC4397F-A18C-410A-974E-ED720989E391Q26823456-ECE955B6-AD20-4646-9AD9-3E6CA5C8D6EAQ26829794-7C88A3B9-8741-463C-AE3A-15225AD8453FQ26866521-CBEDB8A5-B194-410D-91C0-7F8C4EB3DF22Q26998025-FA365637-2450-469A-A427-4AB2577E9781Q26999304-6CAA45D5-E95B-46B1-A37F-F5852C6BDA88Q27000282-871DC25D-7CF8-4744-B398-14C52194BD10Q27002530-BF6BCF00-81EB-4622-B97D-5E56C5C27AFCQ27026972-02FDC25A-E4E5-43CF-8633-26D23B545249Q27851721-A2F7AB37-9D3F-44AC-B012-916452BDF58CQ28117223-376963C7-A0AC-46B9-9DA4-D3D00BC75C28Q28387038-635CF365-AFAB-4174-96CC-2A7F4F2978EBQ28387891-C761D3A7-BB76-4DD6-9063-3021ED1E02AEQ28391713-04BE093F-0667-46BF-AEC4-D7059B16C087Q28710308-AAD5526A-DDFB-4E5D-8F35-0C9F43FF0FCFQ33575734-9B307030-87B1-4DFA-B099-CC102F20A0B4Q33648562-A13E41D9-FF6B-4D45-A2E2-6A9B5FA29141Q33737442-D86AE053-EB59-4651-8320-21B32B0F9722Q33745002-79F60307-C656-435D-9466-71D75E97E97DQ33754114-54A6922A-43E9-444D-8911-6FF4B3FC2742Q33776774-9F615491-48E0-4B01-8D31-3FA8901429A2Q33820667-B590D292-ECC4-4502-9B00-10C1F9D32A64Q33828409-9FA396A0-DDAA-4E1C-BAD8-09A39DF4215EQ33898524-E0AB9B64-F479-48BD-95A6-E1F9B5AB8FCEQ33903223-1C0F97E3-B233-4B41-8F55-25CDC442D5DFQ33910328-BE34DA50-B067-4A06-A326-568EAE01AEBAQ34008617-55B87406-AE68-4FAB-86A1-97815851316EQ34044475-F5919287-AE03-4DB8-BD42-0B7C2C0CC0A0Q34069581-801EDDB0-E9FC-4E96-B94B-552B54FCC1C0Q34078121-3045395E-34B5-4D8B-9252-B19409816EDDQ34091046-E8E36D82-6D3E-4F51-9DF9-7D568D91D59BQ34104191-2796A3A9-ADB9-4E15-832C-2F85F52735FC
P2860
MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers.
@en
MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers.
@nl
type
label
MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers.
@en
MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers.
@nl
prefLabel
MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers.
@en
MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers.
@nl
P2093
P2860
P356
P1476
MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers.
@en
P2093
Aaron J Schetter
Akihiko Gemma
Akiteru Goto
Curtis C Harris
Elise D Bowman
Ewy A Mathe
Haruhiko Sugimura
Izumi Horikawa
Masahiro Seike
P2860
P304
12085-12090
P356
10.1073/PNAS.0905234106
P407
P577
2009-07-13T00:00:00Z